Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.

Brachtl G, Piñón Hofbauer J, Greil R, Hartmann TN.

Ann Hematol. 2014 Mar;93(3):361-74. doi: 10.1007/s00277-013-1967-y. Epub 2013 Nov 28. Review.

2.

The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.

Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V.

Leukemia. 2012 Jun;26(6):1301-12. doi: 10.1038/leu.2011.369. Epub 2012 Jan 6.

PMID:
22289918
3.

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.

Majid A, Lin TT, Best G, Fishlock K, Hewamana S, Pratt G, Yallop D, Buggins AG, Wagner S, Kennedy BJ, Miall F, Hills R, Devereux S, Oscier DG, Dyer MJ, Fegan C, Pepper C.

Leuk Res. 2011 Jun;35(6):750-6. doi: 10.1016/j.leukres.2010.10.022. Epub 2010 Nov 18.

PMID:
21093051
4.

Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.

Dal Bo M, Tissino E, Benedetti D, Caldana C, Bomben R, Del Poeta G, Gaidano G, Rossi FM, Zucchetto A, Gattei V.

Semin Hematol. 2014 Jul;51(3):168-76. doi: 10.1053/j.seminhematol.2014.05.002. Epub 2014 May 15. Review.

PMID:
25048781
5.

Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.

Buggins AG, Levi A, Gohil S, Fishlock K, Patten PE, Calle Y, Yallop D, Devereux S.

Br J Haematol. 2011 Jul;154(2):216-22. doi: 10.1111/j.1365-2141.2011.08725.x. Epub 2011 May 14.

PMID:
21569005
6.

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.

Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, Hartmann TN.

PLoS One. 2011;6(8):e23758. doi: 10.1371/journal.pone.0023758. Epub 2011 Aug 18.

7.

CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.

Ibrahem L, Elderiny WE, Elhelw L, Ismail M.

Blood Cells Mol Dis. 2015 Aug;55(2):154-60. doi: 10.1016/j.bcmd.2015.05.010. Epub 2015 May 29.

PMID:
26142332
8.

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.

Cancer Res. 2009 May 1;69(9):4001-9. doi: 10.1158/0008-5472.CAN-08-4173. Epub 2009 Apr 21.

9.

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

Bulian P, Shanafelt TD, Fegan C, Zucchetto A, Cro L, Nückel H, Baldini L, Kurtova AV, Ferrajoli A, Burger JA, Gaidano G, Del Poeta G, Pepper C, Rossi D, Gattei V.

J Clin Oncol. 2014 Mar 20;32(9):897-904. doi: 10.1200/JCO.2013.50.8515. Epub 2014 Feb 10.

10.

Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.

Aydin S, Grabellus F, Eisele L, Möllmann M, Hanoun M, Ebeling P, Moritz T, Carpinteiro A, Nückel H, Sak A, Göthert JR, Dührsen U, Dürig J.

Eur J Haematol. 2011 Jul;87(1):10-9. doi: 10.1111/j.1600-0609.2011.01626.x.

PMID:
21692849
11.

Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.

Vrbacky F, Smolej L, Vroblova V, Pekova S, Hrudkova M, Cervinka M, Pecka M, Krejsek J, Maly J.

Hematology. 2010 Aug;15(4):210-4. doi: 10.1179/102453309X12583347113898.

PMID:
20670479
13.

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE.

Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x.

14.

Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.

Vaisitti T, Audrito V, Serra S, Bologna C, Arruga F, Brusa D, Buonincontri R, Gizdic B, Deaglio S.

Curr Top Med Chem. 2013;13(23):2955-64. Review.

PMID:
24171772
15.

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.

Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V.

Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.

PMID:
19318232
16.

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.

Baumann T, Delgado J, Santacruz R, Martínez-Trillos A, Rozman M, Aymerich M, López C, Costa D, Carrió A, Villamor N, Montserrat E.

Br J Haematol. 2016 Jan;172(1):48-55. doi: 10.1111/bjh.13788. Epub 2015 Nov 12.

PMID:
26559905
17.

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal-Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G.

Blood. 2008 Jan 15;111(2):865-73. Epub 2007 Oct 24.

18.

Biological prognostic markers in chronic lymphocytic leukemia.

Vroblová V, Smolej L, Vrbacký F, Jankovicová K, Hrudková M, Malý J, Krejsek J.

Acta Medica (Hradec Kralove). 2009;52(1):3-8. Review.

19.

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.

Johansson P, Eisele L, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J, Nückel H.

Leuk Res. 2010 Jul;34(7):892-8. doi: 10.1016/j.leukres.2010.02.038. Epub 2010 Mar 29.

PMID:
20353875
20.

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.

Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Dal Maso L, Del Poeta G, Del Principe MI, Degan M, Gattei V.

J Cell Physiol. 2006 May;207(2):354-63.

PMID:
16331666

Supplemental Content

Support Center